Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 102

1.

Motor phenotype classification in moderate to advanced PD in BioFIND study.

Luo L, Andrews H, Alcalay RN, Poyraz FC, Boehme AK, Goldman JG, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Sutherland M, Kopil C, Naito A, Kang UJ.

Parkinsonism Relat Disord. 2019 Aug;65:178-183. doi: 10.1016/j.parkreldis.2019.06.017. Epub 2019 Jun 23.

PMID:
31255537
2.

Endurance exercise reduces cortisol in Parkinson's disease with mild cognitive impairment.

Smyth N, Skender E, David FJ, Munoz MJ, Fantuzzi G, Clow A, Goldman JG, Corcos DM.

Mov Disord. 2019 Aug;34(8):1238-1239. doi: 10.1002/mds.27719. Epub 2019 May 20. No abstract available.

PMID:
31107979
3.

The Effects of Dual-Task Cognitive Interference and Environmental Challenges on Balance in Huntington's Disease.

Purcell NL, Goldman JG, Ouyang B, Bernard B, O'Keefe JA.

Mov Disord Clin Pract. 2019 Jan 16;6(3):202-212. doi: 10.1002/mdc3.12720. eCollection 2019 Mar.

PMID:
30949551
4.

High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra.

Zhong Z, Merkitch D, Karaman MM, Zhang J, Sui Y, Goldman JG, Zhou XJ.

Radiology. 2019 Apr;291(1):149-157. doi: 10.1148/radiol.2019181042. Epub 2019 Feb 19.

PMID:
30777809
5.

Risk of Parkinson's disease dementia related to level I MDS PD-MCI.

Hoogland J, Boel JA, de Bie RMA, Schmand BA, Geskus RB, Dalrymple-Alford JC, Marras C, Adler CH, Weintraub D, Junque C, Pedersen KF, Mollenhauer B, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2019 Mar;34(3):430-435. doi: 10.1002/mds.27617. Epub 2019 Jan 17.

PMID:
30653248
6.

White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson disease.

Bledsoe IO, Stebbins GT, Merkitch D, Goldman JG.

Neurology. 2018 Dec 11;91(24):e2244-e2255. doi: 10.1212/WNL.0000000000006646. Epub 2018 Nov 14.

PMID:
30429273
7.

Validation of a performance-based assessment of cognitive functional ability in Parkinson's disease.

Holden SK, Medina LD, Hoyt B, Sillau SH, Berman BD, Goldman JG, Weintraub D, Kluger BM.

Mov Disord. 2018 Nov;33(11):1760-1768. doi: 10.1002/mds.27487. Epub 2018 Oct 10.

PMID:
30306618
8.

Flock Immunity.

Goldman JG.

Sci Am. 2018 Sep 18;319(4):16. doi: 10.1038/scientificamerican1018-16a. No abstract available.

PMID:
30273325
9.

Detecting Mild Cognitive Deficits in Parkinson's Disease: Comparison of Neuropsychological Tests.

Hoogland J, van Wanrooij LL, Boel JA, Goldman JG, Stebbins GT, Dalrymple-Alford JC, Marras C, Adler CH, Junque C, Pedersen KF, Mollenhauer B, Zabetian CP, Eslinger PJ, Lewis SJG, Wu RM, Klein M, Rodriguez-Oroz MC, Cammisuli DM, Barone P, Biundo R, de Bie RMA, Schmand BA, Tröster AI, Burn DJ, Litvan I, Filoteo JV, Geurtsen GJ, Weintraub D; IPMDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2018 Nov;33(11):1750-1759. doi: 10.1002/mds.110. Epub 2018 Sep 14. Review.

PMID:
30216541
10.

Reply To: Detection of Alpha-Synuclein in Saliva: The Importance of Preanalytical Assessment.

Kang UJ, Taylor P, Naito A, Goldman JG; BioFIND investigators.

Mov Disord. 2018 Jul;33(6):1031. doi: 10.1002/mds.27424. No abstract available.

PMID:
30134056
11.

Cognitive impairment in Parkinson's disease: a report from a multidisciplinary symposium on unmet needs and future directions to maintain cognitive health.

Goldman JG, Vernaleo BA, Camicioli R, Dahodwala N, Dobkin RD, Ellis T, Galvin JE, Marras C, Edwards J, Fields J, Golden R, Karlawish J, Levin B, Shulman L, Smith G, Tangney C, Thomas CA, Tröster AI, Uc EY, Coyan N, Ellman C, Ellman M, Hoffman C, Hoffman S, Simmonds D.

NPJ Parkinsons Dis. 2018 Jun 26;4:19. doi: 10.1038/s41531-018-0055-3. eCollection 2018. Review.

12.

Biomarkers for cognitive impairment in Lewy body disorders: Status and relevance for clinical trials.

Siderowf A, Aarsland D, Mollenhauer B, Goldman JG, Ravina B.

Mov Disord. 2018 Apr;33(4):528-536. doi: 10.1002/mds.27355. Review.

PMID:
29624752
13.

Scaredy-Cats.

Goldman JG.

Sci Am. 2017 Sep 19;317(4):18-19. doi: 10.1038/scientificamerican1017-18a. No abstract available.

PMID:
29565846
14.

Bird Breakup.

Goldman JG.

Sci Am. 2018 Feb 20;318(3):18. doi: 10.1038/scientificamerican0318-18a. No abstract available.

PMID:
29565350
15.

Nature and Nurture.

Goldman JG.

Sci Am. 2018 Mar 20;318(4):16-17. doi: 10.1038/scientificamerican0418-16a. No abstract available.

PMID:
29557969
16.

Bonobos Like Bullies.

Goldman JG.

Sci Am. 2018 Mar 20;318(4):14. doi: 10.1038/scientificamerican0418-14. No abstract available.

PMID:
29557963
17.

Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment.

Goldman JG, Holden SK, Litvan I, McKeith I, Stebbins GT, Taylor JP.

Mov Disord. 2018 Apr;33(4):503-510. doi: 10.1002/mds.27323. Epub 2018 Feb 28. Review.

PMID:
29488270
18.

Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.

Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P.

Mov Disord. 2018 Mar;33(3):499-500. doi: 10.1002/mds.27339. Epub 2018 Feb 20. No abstract available.

PMID:
29460975
19.

Fruitless Foragers.

Goldman JG.

Sci Am. 2018 Jan 16;318(2):12-13. doi: 10.1038/scientificamerican0218-12. No abstract available.

PMID:
29337951
20.

Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.

Goldman JG, Andrews H, Amara A, Naito A, Alcalay RN, Shaw LM, Taylor P, Xie T, Tuite P, Henchcliffe C, Hogarth P, Frank S, Saint-Hilaire MH, Frasier M, Arnedo V, Reimer AN, Sutherland M, Swanson-Fischer C, Gwinn K; Fox Investigation of New Biomarker Discovery, Kang UJ.

Mov Disord. 2018 Feb;33(2):282-288. doi: 10.1002/mds.27232. Epub 2017 Dec 4.

21.

Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.

Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, van Duijn E, Goetz CG, Weintraub D, Stebbins GT, Martinez-Martin P; members of the MDS Rating Scales Review Committee.

Mov Disord. 2018 Feb;33(2):208-218. doi: 10.1002/mds.27233. Epub 2017 Nov 23. Review.

PMID:
29168899
22.

Wag the Lizard.

Goldman JG.

Sci Am. 2017 Nov 14;317(6):18. doi: 10.1038/scientificamerican1217-18b. No abstract available.

PMID:
29145368
23.

Waning Woods.

Goldman JG.

Sci Am. 2017 Jun 20;317(1):18. doi: 10.1038/scientificamerican0717-18. No abstract available.

PMID:
28632225
24.

Boogie Bears.

Goldman JG.

Sci Am. 2017 Jun 20;317(1):14. doi: 10.1038/scientificamerican0717-14. No abstract available.

PMID:
28632217
25.

Mild cognitive impairment as a risk factor for Parkinson's disease dementia.

Hoogland J, Boel JA, de Bie RMA, Geskus RB, Schmand BA, Dalrymple-Alford JC, Marras C, Adler CH, Goldman JG, Tröster AI, Burn DJ, Litvan I, Geurtsen GJ; MDS Study Group “Validation of Mild Cognitive Impairment in Parkinson Disease”.

Mov Disord. 2017 Jul;32(7):1056-1065. doi: 10.1002/mds.27002. Epub 2017 Jun 12.

26.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

27.

Characterizing Cognitive Impairment in Parkinson's Disease.

Bailey M, Goldman JG.

Semin Neurol. 2017 Apr;37(2):167-175. doi: 10.1055/s-0037-1601894. Epub 2017 May 16. Review.

PMID:
28511257
28.

Which One Is Mom Again?

Goldman JG.

Sci Am. 2017 Mar 14;316(4):18-19. doi: 10.1038/scientificamerican0417-18b. No abstract available.

PMID:
28296850
29.

Corpus callosal atrophy and associations with cognitive impairment in Parkinson disease.

Goldman JG, Bledsoe IO, Merkitch D, Dinh V, Bernard B, Stebbins GT.

Neurology. 2017 Mar 28;88(13):1265-1272. doi: 10.1212/WNL.0000000000003764. Epub 2017 Feb 24.

30.

The Remarkable Timing of Seals.

Goldman JG.

Sci Am. 2016 Dec 20;316(1):17. doi: 10.1038/scientificamerican0117-17. No abstract available.

PMID:
28004722
31.

One's True Nature.

Goldman JG.

Sci Am. 2016 Nov 15;315(6):24. doi: 10.1038/scientificamerican1216-24. No abstract available.

PMID:
28004693
32.

The Brainy Big Cats.

Goldman JG.

Sci Am. 2016 Nov 15;315(6):18. doi: 10.1038/scientificamerican1216-18b. No abstract available.

PMID:
28004663
33.

Taking Direction from a Deer.

Goldman JG.

Sci Am. 2016 Sep 20;315(4):23. doi: 10.1038/scientificamerican1016-23. No abstract available.

PMID:
27798581
34.

Association of GBA Mutations and the E326K Polymorphism With Motor and Cognitive Progression in Parkinson Disease.

Davis MY, Johnson CO, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Quinn JF, Chung KA, Peterson-Hiller AL, Rosenthal LS, Dawson TM, Albert MS, Goldman JG, Stebbins GT, Bernard B, Wszolek ZK, Ross OA, Dickson DW, Eidelberg D, Mattis PJ, Niethammer M, Yearout D, Hu SC, Cholerton BA, Smith M, Mata IF, Montine TJ, Edwards KL, Zabetian CP.

JAMA Neurol. 2016 Oct 1;73(10):1217-1224. doi: 10.1001/jamaneurol.2016.2245.

35.

Neuropsychiatric Issues in Parkinson Disease.

Goldman JG.

Continuum (Minneap Minn). 2016 Aug;22(4 Movement Disorders):1086-103. doi: 10.1212/CON.0000000000000353. Review.

PMID:
27495199
36.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5.

37.

Toddlers' Tool Kits.

Goldman JG.

Sci Am. 2016 Jun;314(6):18. doi: 10.1038/scientificamerican0616-18. No abstract available.

PMID:
27196832
38.

The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.

Kang UJ, Goldman JG, Alcalay RN, Xie T, Tuite P, Henchcliffe C, Hogarth P, Amara AW, Frank S, Rudolph A, Casaceli C, Andrews H, Gwinn K, Sutherland M, Kopil C, Vincent L, Frasier M.

Mov Disord. 2016 Jun;31(6):924-32. doi: 10.1002/mds.26613. Epub 2016 Apr 26.

39.

α-synuclein genetic variability: A biomarker for dementia in Parkinson disease.

Guella I, Evans DM, Szu-Tu C, Nosova E, Bortnick SF; SNCA Cognition Study Group, Goldman JG, Dalrymple-Alford JC, Geurtsen GJ, Litvan I, Ross OA, Middleton LT, Parkkinen L, Farrer MJ.

Ann Neurol. 2016 Jun;79(6):991-9. doi: 10.1002/ana.24664. Epub 2016 May 5.

40.

Lions on the Ledge.

Goldman JG.

Sci Am. 2016 Apr;314(4):12-4. doi: 10.1038/scientificamerican0416-12. No abstract available.

PMID:
27082177
41.

Enhanced learning of natural visual sequences in newborn chicks.

Wood JN, Prasad A, Goldman JG, Wood SM.

Anim Cogn. 2016 Jul;19(4):835-45. doi: 10.1007/s10071-016-0982-5. Epub 2016 Apr 15.

PMID:
27079969
42.

When Love Wins.

Goldman JG.

Sci Am. 2016 Feb;314(2):23. No abstract available.

PMID:
26930822
43.

Ballots for Bison.

Goldman JG.

Sci Am. 2016 Jan;314(1):18. No abstract available.

PMID:
26887186
44.

Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease.

Diederich NJ, Goldman JG, Stebbins GT, Goetz CG.

Mov Disord. 2016 Jan;31(1):11-22. doi: 10.1002/mds.26460. Epub 2015 Dec 9. Review.

PMID:
26650182
45.

Over-the-Counter Monkey Meds.

Goldman JG.

Sci Am. 2015 Nov;313(5):19. No abstract available.

PMID:
26638387
46.

Mild cognitive impairment: an update in Parkinson's disease and lessons learned from Alzheimer's disease.

Goldman JG, Aggarwal NT, Schroeder CD.

Neurodegener Dis Manag. 2015 Oct;5(5):425-43. doi: 10.2217/nmt.15.34. Epub 2015 Oct 30. Review.

47.

From the Pages of Aesop's Fables.

Goldman JG.

Sci Am. 2015 Sep;313(3):24. No abstract available.

PMID:
26455094
48.

Writer's cramp.

Goldman JG.

Toxicon. 2015 Dec 1;107(Pt A):98-104. doi: 10.1016/j.toxicon.2015.09.024. Epub 2015 Sep 21. Review.

PMID:
26391286
49.

Can You Hear Me Now?

Goldman JG.

Sci Am. 2015 Aug;313(2):22. No abstract available.

PMID:
26349135
50.

Tiny Toilets. Some ants build latrines within their nests.

Goldman JG.

Sci Am. 2015 May;312(5):23. No abstract available.

PMID:
26336703

Supplemental Content

Loading ...
Support Center